Biocrates Life Sciences AG
Records under this name other than the patents Biocrates Life Sciences AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 5 of 5 · Back to Biocrates Life Sciences AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,506,665 | Metabolic biomarker set for assessing ovarian cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,791,459 | Method of diagnosing and treating asphyxia Formerly held Lapsed on the fee record Ended Oct 17, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 17, 2025 | From the USPTO record |
| US 10,962,542 | Biomarkers for assessing breast cancer Formerly held Lapsed on the fee record Ended Mar 30, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2025 | From the USPTO record |
| US 10,725,056 | Biomarkers for assessing HIV Formerly held Lapsed on the fee record Ended Jul 28, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 28, 2024 | From the USPTO record |
| US 10,054,604 | Biomarkers for assessing HIV Formerly held Lapsed on the fee record Ended Aug 21, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 21, 2022 | From the USPTO record |